Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Technology Private Placement and M&A Transactions Review Week Ending Jan 28, 2024

Technology Private Placement and M&A Transactions Review Week Ending Jan 28, 2024

by Jonathan Hodson-Walker | Jan 31, 2024 | Technology

Strategy | Financing Transactions Private Placement / Financing Transactions ElevenLabs: The company raised $80 million of Series B venture funding in a deal led by Andreessen Horowitz, Nat Friedman and Daniel Gross on January 22, 2024, putting the company’s...
Consumer Private Placement and M&A Transactions Review Week Ending Jan 28, 2024

Consumer Private Placement and M&A Transactions Review Week Ending Jan 28, 2024

by Jonathan Hodson-Walker | Jan 31, 2024 | Consumer

Strategy | Financing Transactions Private Placement / Financing Transactions Ohalo Genetics: The company raised $40 million of venture funding from undisclosed investors on January 25, 2024. The company is a developer of a plant genetic technology. Protealis: The...
Healthcare Private Placement and M&A Transactions Review Week Ending Jan 28, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending Jan 28, 2024

by Jonathan Hodson-Walker | Jan 31, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Synnovation Therapeutics: The company raised $102 million of Series A venture funding in a deal led by Third Rock Ventures on January 24, 2024, putting the company’s pre-money valuation...
Consumer Private Placement and M&A Transactions Review Week Ending Jan 21, 2024

Consumer Private Placement and M&A Transactions Review Week Ending Jan 21, 2024

by Jonathan Hodson-Walker | Jan 25, 2024 | Consumer

Strategy | Financing Transactions Private Placement / Financing Transactions Bloom Nutrition: The company received $90 million of development capital from Nutrabolt, Amberstone and Mr. Clayton Christopher on January 17, 2024. The company is a producer and seller of...
Healthcare Private Placement and M&A Transactions Review Week Ending Jan 21, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending Jan 21, 2024

by Jonathan Hodson-Walker | Jan 25, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions ClevelandDx: The company raised $75 million through a combination of debt, Series E1 and Series E2 venture funding in a deal led by Novo Holdings on January 17, 2024, putting the...
« Older Entries
Next Entries »

Search

Recent Posts

  • Healthcare Private Placement and M&A Transactions Review Week Ending October 5, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending October 5, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending October 5, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending September 28, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending September 28, 2025

Categories

Archives